Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.1B | 4.1B | 3.7B | 3.4B |
Cost of revenue | 2.3B | 3.0B | 2.2B | 1.9B |
Gross profit | 1.8B | 1.2B | 1.4B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 165.7M | 215.4M | 198.0M | 202.6M |
Operating income | 816.8M | -264.7M | 610.7M | 643.2M |
Non operating interest income | ||||
Income | 87.0M | 69.4M | 322.0M | 207.7M |
Expense | 312.3M | 265.4M | 518.2M | 432.6M |
Other income expense | — | — | — | — |
Pretax income | 708.5M | -561.6M | 570.0M | 694.8M |
Tax provision | 179.2M | -101.0M | 229.0M | 219.5M |
Net income | 485.2M | -460.4M | 341.4M | 475.2M |
Basic EPS | 0.1 | — | 0.1 | 0.1 |
Diluted EPS | 0.1 | — | 0.1 | 0.1 |
Basic average shares | 4.3B | — | 4.0B | 3.4B |
Diluted average shares | 4.3B | — | 4.0B | 3.4B |
EBITDA | 1.5B | 809.8M | 1.5B | 1.6B |
Net income from continuing op. | 708.5M | -561.6M | 570.0M | 694.8M |
Minority interests | -57.1M | 178.9M | -21.1M | -67.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |